Wiebe J - Search Results

1

First-in-Man Coronary Sinus Lead Stabilization Using a Bioresorbable Vascular Scaffold System.

Weipert K, Gemein C, Chasan R, Wiebe J, Doerr O, Boeder N, Erkapic D, Hamm C, Nef H, Schmitt J. Weipert K, et al. Among authors: wiebe j. Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1518-9. doi: 10.1161/CIRCEP.115.003111. Circ Arrhythm Electrophysiol. 2015. PMID: 26671939 No abstract available.

2

A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.

Wiebe J, Hamm C, Nef H. Wiebe J, et al. Catheter Cardiovasc Interv. 2015 Jun;85(7):1184-8. doi: 10.1002/ccd.25833. Epub 2015 Feb 3. Catheter Cardiovasc Interv. 2015. PMID: 25581885

3

"Full bioresorbable jacket": a new era has begun.

Dörr O, Liebetrau C, Hecker F, Wiebe J, Möllmann H, Hamm C, Nef H. Dörr O, et al. Among authors: wiebe j. Herz. 2015 Apr;40(2):255-6. doi: 10.1007/s00059-013-3912-1. Epub 2013 Aug 2. Herz. 2015. PMID: 23903365 No abstract available.

4

Implantation of a novolimus-eluting bioresorbable scaffold with a strut thickness of 100 µm showing evidence of self-correction.

Wiebe J, Bauer T, Dörr O, Möllmann H, Hamm CW, Nef HM. Wiebe J, et al. EuroIntervention. 2015 Jun;11(2):204. doi: 10.4244/EIJY15M02_01. EuroIntervention. 2015. PMID: 25671516 Free article. No abstract available.

5

Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers results.

Wiebe J, Hamm CW, Nef HM. Wiebe J, et al. Curr Opin Cardiol. 2015 Nov;30(6):650-6. doi: 10.1097/HCO.0000000000000229. Curr Opin Cardiol. 2015. PMID: 26447503 Review.

6

Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice.

Wiebe J, Dörr O, Bauer T, Liebetrau C, Boeder N, Möllmann H, Hamm CW, Nef HM. Wiebe J, et al. Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):313-7. doi: 10.1016/j.carrev.2016.03.011. Epub 2016 Mar 28. Cardiovasc Revasc Med. 2016. PMID: 27085220

7

Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.

Blachutzik F, Boeder N, Wiebe J, Mattesini A, Dörr O, Most A, Bauer T, Röther J, Tröbs M, Schlundt C, Achenbach S, Hamm CW, Nef HM. Blachutzik F, et al. Among authors: wiebe j. Clin Res Cardiol. 2017 Apr;106(4):271-279. doi: 10.1007/s00392-016-1048-z. Epub 2016 Oct 18. Clin Res Cardiol. 2017. PMID: 27757522

8

A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives.

Nef HM, Wiebe J, Foin N, Blachutzik F, Dörr O, Toyloy S, Hamm CW. Nef HM, et al. Among authors: wiebe j. Int J Cardiol. 2017 Jan 15;227:127-133. doi: 10.1016/j.ijcard.2016.11.033. Epub 2016 Nov 9. Int J Cardiol. 2017. PMID: 27863289 Review.

9

Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis.

Boeder NF, Johnson V, Dörr O, Wiebe J, Elsässer A, Möllmann H, Hamm CW, Nef HM, Bauer T. Boeder NF, et al. Among authors: wiebe j. Int J Cardiol. 2017 Mar 15;231:73-77. doi: 10.1016/j.ijcard.2016.11.280. Epub 2016 Nov 24. Int J Cardiol. 2017. PMID: 27899203

10

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison.

Wiebe J, Dörr O, Ilstad H, Husser O, Liebetrau C, Boeder N, Bauer T, Möllmann H, Kastrati A, Hamm CW, Nef HM. Wiebe J, et al. JACC Cardiovasc Interv. 2017 Mar 13;10(5):477-485. doi: 10.1016/j.jcin.2016.11.034. Epub 2017 Feb 15. JACC Cardiovasc Interv. 2017. PMID: 28216214 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters